...
首页> 外文期刊>American Journal of Hematology >Aquagenic pruritus in polycythemia vera: Characteristics and influence on quality of life in 441 patients
【24h】

Aquagenic pruritus in polycythemia vera: Characteristics and influence on quality of life in 441 patients

机译:真性红细胞增多症的水源性瘙痒:441例患者的特征及其对生活质量的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Aquagenic pruritus (AP) is a symptom typical for polycythemia vera, but very little is known about its exact frequency, characteristics, influence on quality of life, and proper treatment. Therefore, we investigated these aspects in a large cohort of German patients with polycythemia vera using a patient directed questionnaire. Our analysis revealed that 301 of 441 analyzed patients suffered from AP. In 64.8%, AP occurred on average 2.9 years prior to diagnosis of polycythemia vera. Only in 15.4% did this lead to a hematological investigation. AP occurs primarily on the trunk and proximal parts of the extremities. Most patients complain about itching (71.8%), the remainder about tickling, stinging, or burning sensations. Forty-four patients (14.6%) classified the pruritus as "unbearable." Patients with AP reported reduced global health status and higher fatigue, pain, and dyspnea. Only 24% of patients received pruritus specific treatment for pruritus consisting mostly of histamine antagonists, which ameliorated symptoms in about half of the patients. In 5.6% of patients, polycythemia vera directed therapy (phlebotomy/cytoreduction) resolved the symptoms. In summary, AP is a serious symptom in patients with polycythemia vera, which until recently was difficult to treat. The advent of the novel JAK2 inhibitors, however, may open new ways for therapy. Am. J. Hematol. 88:665-669, 2013.
机译:水源性瘙痒(AP)是真性红细胞增多症的典型症状,但对其确切的频率,特征,对生活质量的影响以及适当的治疗知之甚少。因此,我们使用患者指导调查表在德国队列性红细胞增多症患者中调查了这些方面。我们的分析显示,在分析的441名患者中,有301名患有AP。在确诊为真性红细胞增多症之前,AP平均发生时间为2.9年,占64.8%。仅导致15.4%的血液学检查。 AP主要发生在四肢的躯干和近端。大多数患者抱怨瘙痒(71.8%),其余患者则感到瘙痒,刺痛或灼痛感。四十四例(14.6%)将瘙痒症归类为“难以忍受”。患有AP的患者报告总体健康状况下降,并且疲劳,疼痛和呼吸困难加剧。只有24%的患者接受了针对瘙痒的特异性治疗,这种瘙痒主要由组胺拮抗剂组成,可减轻约一半患者的症状。在5.6%的患者中,真性红细胞增多症的定向治疗(静脉切开术/细胞减少术)可以缓解症状。总之,AP是真性红细胞增多症患者的一种严重症状,直到最近仍难以治疗。然而,新型JAK2抑制剂的出现可能为治疗开辟新的途径。上午。 J. Hematol。 88:665-669,2013。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号